Evidence map›Paper›PMID 40673672›Full record

ArticleThe Journal of infectious diseases2025

Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa Infections.

Clemens Dierks, Pinkus Tober-Lau, Luzia Veletzky, Ziyue Wang, Boris Zühlke, Daniela Ludwig, Agathe Niewienda, Anja Freiwald, Lara Bardtke, Paolo Kroneberg and 10 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Clemens DierksInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-4560-8939
Pinkus Tober-LauDepartment of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-9148-3663
Luzia VeletzkyDivision of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6136-8170
Ziyue WangInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-4121-4799
Boris ZühlkeInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5527-2626
Daniela LudwigCore Facility High Throughput Mass Spectrometry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Agathe NiewiendaCore Facility High Throughput Mass Spectrometry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-0993-1026
Anja FreiwaldCore Facility High Throughput Mass Spectrometry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Lara BardtkeDepartment of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-5302-9507
Paolo KronebergDepartment of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Daniel StelzlCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0001-8745-0028
Jennifer HergethCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Rella Zoleko ManegoCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0001-7425-2794
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0003-2658-8706
Selidji Todagbe AgnandjiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0003-4693-4207
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0003-3197-5946
Michael MüllederCore Facility High Throughput Mass Spectrometry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-9792-3861
Michael RamharterCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0002-9259-1885
Markus RalserInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-9535-7413
Florian KurthDepartment of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-3807-473X

Funding

European and Developing Countries Clinical Trials Partnership 2 programmeEuropean Union A12/B-2Federal Ministry of Science, Research and Economy of AustriaGerman Center for Infection Research TI 07.001German Federal Ministry of Education and Research 031L0286B
6 · The paper itself

Abstract

backgroundLoiasis, caused by the filarial nematode Loa loa, imposes a significant disease burden in endemic regions in West and Central Africa. Manifestations include adult worms in soft tissue (e.g., the conjunctiva of the eye) and microfilaria in peripheral blood, with clinical presentations ranging from asymptomatic infections to life-threatening organ involvement. Diagnosis remains challenging due to variable microfilaria counts, frequent amicrofilaremic occult infections, and unreliable serological tests. The untargeted plasma proteome reflects broad (patho-)physiological responses, providing valuable insights into the host and disease.

methodsApplying high-throughput plasma proteomics, we investigated the host responses of 274 patients with different L. loa disease states, including occult loiasis (n = 148), microfilaremia (n = 42), or both (n = 84), compared to 136 L. loa-negative controls. Differentially abundant proteins between L. loa-infected individuals and negative controls were validated using targeted proteomics.

resultsFive proteins (IGHG3, IGHG4, ACTBL2, LCP1, and IGLV9-49) were elevated in infected individuals compared to healthy controls. IGHG3, IGHG4, ACTB, and LCP1 increased from L. loa negative over individuals with history of eye worm migration to microfilaremic patients, indicating a comparatively pronounced proteomic host response to microfilaria in the blood. Sixty-three proteins differed depending on self-reported symptoms. The proteomic signatures enabled accurate classification of individuals with occult loiasis (area under the receiver operating characteristic curve [AUROC] = 0.73) and microfilaremia (AUROC = 0.84) by a random forest machine learning model.

conclusionsOverall, infection with Loa loa alters the host plasma proteome, exhibiting distinct host responses in different infection states and allowing for molecular disease classification of this highly neglected parasitic disease.

Indexed as

LoaLoiasisProteomeProteomicsAdolescentAdultAnimalsFemaleHumansMaleMicrofilariaeMiddle AgedYoung AdultProteomeinfectious diseaseLoa loamass spectrometryneglected tropical diseaseplasma proteomics

Identifiers

PMID40673672
PMCPMC12455300

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.